{
     "PMID": "26454240",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20160920",
     "LR": "20151215",
     "IS": "1872-7549 (Electronic) 0166-4328 (Linking)",
     "VI": "297",
     "DP": "2016 Jan 15",
     "TI": "Sensorimotor recovery from cortical injury is accompanied by changes on norepinephrine and serotonin levels in the dentate gyrus and pons.",
     "PG": "297-306",
     "LID": "10.1016/j.bbr.2015.10.009 [doi] S0166-4328(15)30223-0 [pii]",
     "AB": "Monoamines such as norepinephrine (NE) and serotonin (5-HT) have shown to play an important role in motor recovery after brain injury. The effects elicited by these neurotransmitters have been reported as distal from the area directly affected. Remote changes may take place over minutes to weeks and play an important role in post-stroke recovery. However, the mechanisms involved in spontaneous recovery have not been thoroughly delineated. Therefore, we determined the NE and 5-HT content, in the pons and hippocampal dentate gyrus (DG) as well as motor deficit and spontaneous activity in rats after 3, 10 and 20 days cortical iron injection. Three days post-lesion the pontine NE content diminished, this effect was accompanied by deficient spontaneous activity and impaired sensorimotor evaluation. Ten and twenty days after lesion the NE levels were similar to those of control group, and animals also showed behavioral recovery. Monoamines content on DG 3 days post-lesion showed no differences as compared to controls. Interestingly, ten and twenty days after cortical injury, animals showed increased NE and 5-HT. These results suggest that behavioral recovery after brain damage involve changes on monoamines levels on DG, an important structure to plastic processes. In addition, the results herein support evidence to propose these neurotransmitters as key molecules to functional recovery in the central nervous system.",
     "CI": [
          "Copyright (c) 2015 Elsevier B.V. All rights reserved."
     ],
     "FAU": [
          "Ramos-Languren, Laura E",
          "Gonzalez-Pina, Rigoberto",
          "Montes, Sergio",
          "Chavez-Garcia, Norma",
          "Avila-Luna, Alberto",
          "Baron-Flores, Veronica",
          "Rios, Camilo"
     ],
     "AU": [
          "Ramos-Languren LE",
          "Gonzalez-Pina R",
          "Montes S",
          "Chavez-Garcia N",
          "Avila-Luna A",
          "Baron-Flores V",
          "Rios C"
     ],
     "AD": "Depto. de Neuroquimica, Instituto Nacional de Neurologia y Neurocirugia, MVS, SSA, Mexico City, Mexico; Maestria en Ciencias Farmaceuticas, Universidad Autonoma Metropolitana, Unidad Xochimilco, Mexico City, Mexico; Laboratorio de Neuroplasticidad, Division de Neurociencias, Torre de Investigacion, Instituto Nacional de Rehabilitacion, Mexico City, Mexico. Laboratorio de Neuroplasticidad, Division de Neurociencias, Torre de Investigacion, Instituto Nacional de Rehabilitacion, Mexico City, Mexico. Depto. de Neuroquimica, Instituto Nacional de Neurologia y Neurocirugia, MVS, SSA, Mexico City, Mexico. Depto. de Neuroquimica, Instituto Nacional de Neurologia y Neurocirugia, MVS, SSA, Mexico City, Mexico. Laboratorio de Neuroplasticidad, Division de Neurociencias, Torre de Investigacion, Instituto Nacional de Rehabilitacion, Mexico City, Mexico. Neurofarmalogia Molecular, Departamento de Sistemas Biologicos, Universidad Autonoma Metropolitana, Unidad Xochimilco, Mexico City, Mexico. Depto. de Neuroquimica, Instituto Nacional de Neurologia y Neurocirugia, MVS, SSA, Mexico City, Mexico; Maestria en Ciencias Farmaceuticas, Universidad Autonoma Metropolitana, Unidad Xochimilco, Mexico City, Mexico; Neurofarmalogia Molecular, Departamento de Sistemas Biologicos, Universidad Autonoma Metropolitana, Unidad Xochimilco, Mexico City, Mexico. Electronic address: crios@uam.xoc.mx.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20151008",
     "PL": "Netherlands",
     "TA": "Behav Brain Res",
     "JT": "Behavioural brain research",
     "JID": "8004872",
     "RN": [
          "0 (Ferrous Compounds)",
          "333DO1RDJY (Serotonin)",
          "S3Y25PHP1W (ferrous chloride)",
          "X4W3ENH1CV (Norepinephrine)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Brain Injuries/complications/*metabolism",
          "Dentate Gyrus/*metabolism",
          "Disease Models, Animal",
          "Disease Progression",
          "Ferrous Compounds",
          "Male",
          "Motor Activity/physiology",
          "Movement Disorders/etiology/metabolism",
          "Neuronal Plasticity/physiology",
          "Norepinephrine/*metabolism",
          "Pons/*metabolism",
          "Random Allocation",
          "Rats, Wistar",
          "Recovery of Function/*physiology",
          "Serotonin/*metabolism"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Diaschisis",
          "Ferrous chloride",
          "Hippocampus",
          "Locus coeruleus",
          "Raphe nucleus"
     ],
     "EDAT": "2015/10/11 06:00",
     "MHDA": "2016/09/22 06:00",
     "CRDT": [
          "2015/10/11 06:00"
     ],
     "PHST": [
          "2015/08/06 00:00 [received]",
          "2015/10/02 00:00 [revised]",
          "2015/10/03 00:00 [accepted]",
          "2015/10/11 06:00 [entrez]",
          "2015/10/11 06:00 [pubmed]",
          "2016/09/22 06:00 [medline]"
     ],
     "AID": [
          "S0166-4328(15)30223-0 [pii]",
          "10.1016/j.bbr.2015.10.009 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Behav Brain Res. 2016 Jan 15;297:297-306. doi: 10.1016/j.bbr.2015.10.009. Epub 2015 Oct 8.",
     "term": "hippocampus"
}